Neutrophil heterogeneity and plasticity in wound healing
伤口愈合中中性粒细胞的异质性和可塑性
基本信息
- 批准号:10712032
- 负责人:
- 金额:$ 37.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-05 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AgeAnti-Inflammatory AgentsBackBehaviorBioinformaticsBiologyBurn injuryCellsClinicalCommunitiesDataDiseaseEnvironmentEquilibriumFlow CytometryGenetic TranscriptionGoalsHeterogeneityHumanImageImmuneImmune responseInfectionInflammationInjuryLeukocytesMethodsModelingMolecularOrgan failureOutcomePathologicPathway interactionsPatientsPersonsPhenotypePlayProcessResearchRoleSamplingShockSiteSystemTimeTissuesTraumaTraumatic injuryValidationZebrafishanalysis pipelineburn modelcell typefirst respondergenomic datahigh dimensionalityin vivoinnovationinterdisciplinary approachmethod developmentmigrationmodel organismmortalitymouse modelmultimodalityneutrophilnovelpre-clinicalpreventprogramsresponsesevere burnssingle cell technologytranscriptomewound healing
项目摘要
PROJECT SUMMARY/ABSTRACT
The long-term goal of my research program is to understand neutrophil heterogeneity and functions in diverse
tissues and biomedical contexts. We have combined high-dimensional and single-cell profiling with integrated
bioinformatics approaches to defining context-specific neutrophil landscape. Neutrophils, the most abundant
human immune cell type, play crucial, first-line roles in regulating swift responses against infections and
pathological responses. Emerging evidence has shown that neutrophil response is systematic and context-
specific with distinct phenotypes and functions. Burn injuries are among the most common traumatic injuries
worldwide. In severe cases, patients can die of infection, shock, and/or organ failure, requiring expeditious
clinical responses. Proper wound healing requires a coordinated time-dependent balance of pro- and anti-
inflammatory immune pathways to prevent irreversible systemic damage. Despite being the first to mobilize to
sites of injury, there remains little known about neutrophil heterogeneity, their fates, and which factors control
the plasticity of neutrophils in wound healing. We hypothesize that neutrophils' cellular and molecular landscape
change over time during the wound healing process, and that blood neutrophils could be a marker to predict
complications and outcomes in severe burn injury. To this end, we will focus on two important discoveries in
neutrophil biology over the past decade: (i) neutrophil heterogeneity and adaption to specific tissue environments
revealed by high-dimensional flow cytometry and single-cell transcriptome data and (ii) neutrophil reverse
migration phenotypes, shown in model organisms demonstrating that neutrophils migrate back to the vasculature
in response to inflammation. In this MIRA application, I plan to 1) identify transcriptional and spatial landscapes
of neutrophils and their interactions with other immune cells in human burns using multimodal single-cell profiling
approaches, 2) define reverse migration neutrophil phenotypes in human burns by performing cross-species
single-cell transcriptome analyses of neutrophil heterogeneity in wound healing using clinical samples and pre-
clinical zebrafish burn models, and 3) develop analysis pipelines and methods to predict neutrophil behaviors
defined by imaging using single-cell genomic data in humans and publicly available data from zebrafish and
mouse models. In the next five years, I will establish a research program to study neutrophil heterogeneity and
plasticity in wound healing using multidisciplinary approaches. Our approaches are innovative because we will
employ: (i) state-of-the-art single-cell technologies, (ii) novel integrated bioinformatics method development and
analysis, and (iii) profiling data cross-tissues in humans with in vivo validation models using model organisms.
These studies will generate comprehensive data and provide cellular and molecular landscapes of neutrophil
heterogeneity to the community studying wound repair and neutrophil biology.
项目摘要/摘要
我的研究计划的长期目标是了解中性粒细胞的异质性和在不同的
组织和生物医学背景。我们将高维和单细胞分析与集成
生物信息学方法确定特定背景的中性粒细胞景观。中性粒细胞,最丰富的
人类免疫细胞类型,在调节对感染的快速反应和
病理性反应。新出现的证据表明,中性粒细胞的反应是系统性的和背景的-
特有的,具有不同的表型和功能。烧伤是最常见的创伤之一。
全世界。在严重情况下,患者可能死于感染、休克和/或器官衰竭,需要迅速
临床反应。适当的伤口愈合需要协调一致的时间依赖平衡的支持和反对
炎性免疫途径,防止不可逆的全身损害。尽管是第一个动员到
对于中性粒细胞的异质性、它们的命运以及哪些因素控制,人们仍然知之甚少。
中性粒细胞在伤口愈合中的可塑性。我们假设中性粒细胞的细胞和分子景观
在伤口愈合过程中随着时间的变化,血液中的中性粒细胞可能是一个预测的标志
严重烧伤的并发症和转归。为此,我们将重点关注以下两个重要发现
过去十年的中性粒细胞生物学:(I)中性粒细胞的异质性和对特定组织环境的适应
高维流式细胞术和单细胞转录组数据显示:(Ii)中性粒细胞逆转
迁移表型,在模型生物中显示中性粒细胞迁移回血管系统
作为对炎症的反应。在这个Mira应用程序中,我计划1)识别转录和空间景观
应用多模式单细胞图谱研究烧伤患者中性粒细胞及其与其他免疫细胞的相互作用
方法,2)通过跨物种研究确定烧伤患者中性粒细胞的反向迁移表型
单细胞转录组分析伤口愈合过程中中性粒细胞的异质性
临床斑马鱼烧伤模型,以及3)开发预测中性粒细胞行为的分析管道和方法
通过使用人类单细胞基因组数据和斑马鱼的公开数据进行成像定义
老鼠模型。在接下来的五年里,我将建立一个研究项目,研究中性粒细胞的异质性和
用多学科方法研究伤口愈合中的可塑性。我们的方法是创新的,因为我们将
使用:(一)最先进的单细胞技术,(二)新的综合生物信息学方法的开发和
分析,以及(Iii)通过使用模型生物体的活体验证模型来分析人类的跨组织数据。
这些研究将产生全面的数据,并提供中性粒细胞的细胞和分子图景
研究伤口修复和中性粒细胞生物学的社区的异质性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Huy Quang Dinh其他文献
Huy Quang Dinh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 37.54万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 37.54万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 37.54万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 37.54万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 37.54万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 37.54万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 37.54万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 37.54万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 37.54万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 37.54万 - 项目类别:














{{item.name}}会员




